Abstract:
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B.
Abstract:
Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B.
Abstract:
A lens driving device, comprises a base; a casing fixed to the base; a coil bracket disposed within the casing; a coil wound on the coil bracket, a spring disposed within the casing, a drive rod; and a lens holder; wherein, one end of the spring is fixed to the base; one end of the drive rod is fixed to the other end of the spring, and the other end of the drive rod extends out of the casing. The lens holder is slidably fixed to the exposed portion of the drive rod. The lens holder is held stationary with respect to the drive rod by static friction between the drive rod and the lens holder. A driving signal may be applied to the coil to move the lens holder. The driving signal has the characteristic of making the current flowing through the coil slowly increase and then rapidly decrease, or to rapidly increase and then slowly decrease. The drive current is preferably a sawtooth pulse train, with each pulse causing movement of the lens holder in the micron range or below.
Abstract:
A method of simulating operation of a VLSI interconnect structure having capacitive and inductive coupling between nodes thereof. A matrix X and a matrix Y containing different combinations of passive circuit element values for the interconnect structure are obtained where the element values for each matrix include inductance L and inverse capacitance P. An adjacency matrix A associated with the interconnect structure is obtained. Numerical integration is used to solve first and second equations, each including as a factor the product of the inverse matrix X1 and at least one other matrix, with first equation including X1Y, X1A, and X1P, and the second equation including X1A and X1P.
Abstract:
The invention discloses a tissue engineering graft, comprising:(a) pharmaceutically-acceptable biodegradable material; and (b) seed cells, which can be inoculated on the described biodegradable material and are selected from:(i) fibroblasts; (ii) adipose derived cells, or (iii) mixture of dermal fibroblasts and ASCs according to the ratio of 1:10000-10000:1. The graft can be prepared by mixing of seed cell and pharmaceutically-acceptable biodegradable material, obtaining a construct of seed cells and pharmaceutically-acceptable biodegradable material, then culturing the construct in a bioreactor in vitro. The graft can be used for repairing the defect of tendon tissues.
Abstract:
The present invention relates to a method in a graphics system for creating a graphics stream allowing to form a three-dimensional graphics data, the graphics stream consisting of segments. The graphics stream is divided into at least a first segment and a second segment, the first segment comprises two-dimensional graphics data and the second segment comprises a depth map for the two-dimensional graphics data. The graphics stream can be decoded by a decoder to form two data sequences to be output separately to a display device for rendering a three-dimensional subtitle or graphics image for a three-dimensional video image.
Abstract:
Embodiments of the invention disclose a method for K-only (gray/black) object rendering in a high-speed color controller of a printing system. The method includes setting a flag to indicate selection of a K-only text and barcode print preference from a user of a print system, receiving one or more objects to be printed by the print system, the one or more objects including at least one of a text object and a barcode object, determining whether an input color space for the at least one text object and barcode object should be converted to K-only black ink, and rendering the at least one of the text object and the barcode object as K-only black ink if the input color space is determined to be converted to K-only black ink.
Abstract:
A method and system for generating halftone tables, using a spot function, subdivides the pixels within the halftone cell of a halftone matrix into a plurality of sub-pixels, determines the value of the spot function corresponding to the position of each of the sub-pixels within the halftone matrix, repeats the subdividing and determining for all of the sub-pixels in the halftone matrix, ranks the values for the entire halftone matrix, normalizes the ranked values, generates a cumulative histogram based upon the normalized values, and stores the cumulative histogram as a halftone table.
Abstract:
An apparatus and method for automatic operation of a refrigeration system to provide refrigeration power to a catheter for tissue ablation or mapping. The primary refrigeration system can be open loop or closed loop, and a precool loop will typically be closed loop. Equipment and procedures are disclosed for bringing the system to the desired operational state, for controlling the operation by controlling refrigerant flow rate, for performing safety checks, and for achieving safe shutdown.
Abstract:
Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B.